for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Vaccitech, startup behind Oxford COVID-19 vaccine tech, falls 20% in Nasdaq debut

April 30 (Reuters) - American depositary shares of Vaccitech, which co-invented the COVID-19 vaccine developed by AstraZeneca Plc and Oxford University, fell nearly 20% in their market debut on Friday, giving the biotech firm a market value of about $464 million.

The company’s shares opened at $13.62, below the initial public offering price of $17. (Reporting by Vishwadha Chander in Bengaluru; Editing by Aditya Soni)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up